| Literature DB >> 32025000 |
Osamu Kikuchi1, Gina N Duronio1, Nilay S Sethi2,3,4, Matthew D Stachler1,5,6, James M McFarland7, Ruben Ferrer-Luna1,7, Yanxi Zhang1, Chunyang Bao1, Roderick Bronson8, Deepa Patil5, Francisco Sanchez-Vega9, Jie-Bin Liu1, Ewa Sicinska6, Jean-Bernard Lazaro10,11, Keith L Ligon1,7,6, Rameen Beroukhim1,7, Adam J Bass12,13,14.
Abstract
Somatic alterations in cancer genes are being detected in normal and premalignant tissue, thus placing greater emphasis on gene-environment interactions that enable disease phenotypes. By combining early genetic alterations with disease-relevant exposures, we developed an integrative mouse model to study gastric premalignancy. Deletion of Trp53 in gastric cells confers a selective advantage and promotes the development of dysplasia in the setting of dietary carcinogens. Organoid derivation from dysplastic lesions facilitated genomic, transcriptional and functional evaluation of gastric premalignancy. Cell cycle regulators, most notably Cdkn2a, were upregulated by p53 inactivation in gastric premalignancy, serving as a barrier to disease progression. Co-deletion of Cdkn2a and Trp53 in dysplastic gastric organoids promoted cancer phenotypes but also induced replication stress, exposing a susceptibility to DNA damage response inhibitors. These findings demonstrate the utility of mouse models that integrate genomic alterations with relevant exposures and highlight the importance of gene-environment interactions in shaping the premalignant state.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32025000 PMCID: PMC7031028 DOI: 10.1038/s41588-019-0574-9
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330